Your session is about to expire
← Back to Search
[18F]DPA714 PET Imaging for Brain Inflammation
Study Summary
This trial is studying a brain inflammation marker called TSPO using a PET scan. They will also be doing MRI's to study microstructure damages caused by neuroinflammation in different parts of the brain.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am at least 8 years old.I have complications like a large fluid-filled swelling, bleeding, or fluid buildup in my brain.My genetic test shows I have low-affinity TSPO binding sites.I have medulloblastoma and will get 36 Gy of radiation to my brain and spine.I am not breastfeeding as I might be exposed to radiation.My genetic test shows I have a specific variant in the TSPO gene.I need sedation for PET scans.
- Group 1: Participants
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Who qualifies to register for this medical research project?
"This clinical trial seeks out 22 participants between the ages of 8 and 39 who are suffering from medulloblastoma. Principally, candidates must be at least 8 years old to qualify."
Is this research initiative welcoming elderly participants?
"The criteria for participation in this trial stipulates that all candidates must fall between 8 and 39 years of age."
Is there an opportunity to participate in this experiment for those seeking treatment?
"Affirmative. According to records posted on clinicaltrials.gov, this medical research is still recruiting participants since its inception on July 5th 2022. The study is looking for 22 individuals at a single location."
To what extent could [18F]DPA714 potentially harm patients?
"Analysts working for Power have rated [18F]DPA714 a 2 on their safety scale, as there is some research indicating its security but no evidence of effectiveness from Phase 2 trials."
How many individuals are actively engaging in this research project?
"Affirmative. According to the information hosted on clinicaltrials.gov, this medical study is currently recruiting volunteers. It was first posted on July 5th 2022 and last updated on August 17th 2022 with a goal of obtaining 22 participants from one site."
Share this study with friends
Copy Link
Messenger